ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Allergy Immunology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,268Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 18

$1.65M Total Retail Price of All Prescriptions

Rank: 2 out of 18

284 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 284 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 14,558 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

64% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $239 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 707 681 1 5
NEXIUM 657 629 2 3
PLAVIX 409 386 3 15
METOPROLOL TARTRATE 368 356 4 14
SYNTHROID 336 326 5 8
AMLODIPINE BESYLATE 300 274 6 4
JANUMET 294 273 7 19
LIDODERM 276 274 8 21
SIMVASTATIN 262 239 9 1
ZETIA 229 229 10 28
BENICAR HCT 210 197 11 31
CARVEDILOL 209 189 12 32
ZOLPIDEM TARTRATE 197 195 13 6
CREON 181 158 14 34
NAMENDA 181 181 14 34
CLOPIDOGREL 174 159 16 36
GLYBURIDE-METFORMIN HCL 166 150 R 17 38
BENICAR 166 153 17 38
FUROSEMIDE 164 161 19 25
VYTORIN 163 163 20 40
FLUTICASONE PROPIONATE 155 140 21 2
BYSTOLIC 152 143 22 44
MECLIZINE HCL 144 142 23 46
VOLTAREN 142 137 24 47
LIPITOR 141 141 25 23
METOPROLOL SUCCINATE 137 132 26 13
LOSARTAN POTASSIUM 132 122 27 48
ATENOLOL 131 131 28 22
TOPROL XL 126 126 29 53
LANSOPRAZOLE 125 117 30 54
SINGULAIR 124 117 31 11
ATORVASTATIN CALCIUM 122 116 32 7
ENALAPRIL MALEATE 122 117 32 26
SPIRIVA 122 115 32 37
DIOVAN HCT 114 102 35 59
DEXILANT 111 108 36 60
DIOVAN 109 109 37 61
TRIBENZOR 108 108 38 62
CLONIDINE HCL 107 103 39 63
LEVOTHYROXINE SODIUM 105 93 40 17
JANUVIA 104 83 41 43
TAMSULOSIN HCL 103 102 42 64
METFORMIN HCL 101 97 43 27
LEXAPRO 98 92 44 66
CELEBREX 95 81 45 68
COUMADIN 95 95 45 68
LOSARTAN-HYDROCHLOROTHIAZIDE 94 94 47 70
LUNESTA 92 92 48 71
VESICARE 92 80 48 71
ACTOS 90 86 50 73
CLOTRIMAZOLE-BETAMETHASONE 90 90 50 73
TRILIPIX 88 88 52 75
MICARDIS 87 87 53 76
EXELON 85 85 54 77
PROCTOZONE-HC 84 84 55 78
HYDROCHLOROTHIAZIDE 84 84 55 18
ATELVIA 82 76 57 81
DONEPEZIL HCL 80 80 58 82
GLIMEPIRIDE 77 77 59 86
NITROGLYCERIN PATCH 77 77 59 86
PENNSAID 76 76 61 89
ISOSORBIDE MONONITRATE ER 75 75 62 90
CLOTRIMAZOLE 73 69 63 94
MICARDIS HCT 73 73 63 94
ADVAIR DISKUS 70 69 65 12
ULORIC 68 63 66 98
ZOVIRAX 68 65 66 98
AZOR 68 53 66 98
EVISTA 68 68 66 98
ACTONEL 67 67 70 102
ESCITALOPRAM OXALATE 66 62 71 103
KOMBIGLYZE XR 62 52 72 106
SINGLE USE SWAB 59 55 73 108
LYRICA 59 46 73 49
AVODART 58 58 75 110
AMMONIUM LACTATE 58 53 75 110
EXFORGE 57 57 77 112
ALCOHOL SWABS 57 55 77 112
CILOSTAZOL 57 45 77 52
RAMIPRIL 57 57 77 55
NASONEX 56 56 81 29
HYDRALAZINE HCL 55 43 82 115
AZITHROMYCIN 54 52 83 20
TRADJENTA 54 54 83 117
ENALAPRIL-HYDROCHLOROTHIAZIDE 52 52 85 121
AMLODIPINE BESYLATE-BENAZEPRIL 50 37 86 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.